MedTech20 Annual Conference
Click the profiles below to learn about our speakers
Mr Dan Grant
Managing Director & CEO
Chief Executive Officer
Mr Ian Burgess
Chief Executive Officer, Medical Technology Association of Australia
Previously, the CEO of the Australian Dental Association (NSW Branch) the peak membership body representing dentists in NSW and the ACT, providing continuing education, member services and advocacy to support dentists and promote oral health. Mr Burgess was CEO of the Ortho Group Pty Limited (OGL) a privately owned health business, comprising orthopaedic and sports medicine consulting and surgery, a hospital and a day surgery, radiology centres and medical supplies businesses.
Between 2007 – 2010 CEO of the Australian Orthopaedic Association Limited (AOA): Membership body representing orthopaedic surgeons, providing specialist training, continuing education and advocacy on behalf of the orthopaedic profession. He holds an MBA from Macquarie University and a Bachelor of Economics from the Australian National University. He is a member of the Australian Institute of Company Directors and a non-executive director of Red Nose Ltd and SIDS and Kids (ACT) Ltd.
Adj. Prof. John Skerritt
Deputy Secretary, Health Products Regulation Group, TGA, Department of Health
He was formerly a Deputy Secretary in the Victorian Government and has extensive experience in medical, agricultural and environmental policy, regulation, research management, technology application and commercialisation. John was previously the Deputy Chief Executive Officer of a Commonwealth Statutory Authority, a Ministerial appointee on the Gene Technology Technical Advisory Committee and Chair of the Board of a major international technical organisation. During the 1990s he held senior management positions in The Commonwealth Scientific and Industrial Research Organisation and Cooperative Research Centres.
He has significant experience on Boards of international and national organisations and more than 25 years’ experience in negotiating and leading international technical and commercial collaborations. He is currently Vice-Chair of the International Coalition of Medicines Regulatory Authorities and Chair of the Scientific Advisory Council of the Centre for Innovation in Regulatory Science.
• Is an Adjunct Full Professor of the Universities of Sydney, Queensland and Canberra.
• Has a University Medal and PhD from the University of Sydney.
• Is a graduate of the Senior Executive Programs of London Business School and of IMD Business School, Switzerland.
• Is a Fellow of the Academy of Technological Sciences and Engineering.
• Is a Fellow of the Institute of Public Administration of Australia (Victoria).
Mr Paul Dale
Director of Policy
Mr Ben Harris
Director of Policy and Research, PHA
Ms Natalie Lawandi
Snr Manager, Healthcare Economics, Policy & Reimbursement, Medtronic
Currently, Natalie holds a senior leadership position at Medtronic leading the Healthcare Economics, Health Policy and Reimbursement (HEP&R) activities in ANZ, including regional and global appointments. She is a current member of the MTAA Public Affairs Committee and represents MTAA on the Quality of Information & Guidance Industry Working Group . She is a member of the Health Information Management Association of Australia (HIMAA) and Health Technology international (HTAi). She holds a Bachelor of Applied Science (Health Information Management) and a Master of Health Science (Clinical Data Management) from the University of Sydney.
Hon Karen Andrews MP
Minister for Industry, Science and Technology, Australian Commonwealth Government
Mr Dan Grant
Managing Director & CEO, MTPConnect
Ms Susan Martin
Managing Director, Australia & New Zealand, Johnson & Johnson Medical
Before being appointed Managing Director, she was most recently the Asia Pacific Franchise Lead for JJMD’s Cardiovascular Specialty Solutions business and responsible for providing regional perspective and insights that fed into the business’ global franchise strategy and pipeline. She has also served as the Country Director for JJMD’s New Zealand business.
She is also a member and co-chair of the Johnson & Johnson Family of Companies Australia and New Zealand Board.
She is a champion of, and role model for, women in the medical devices sector and a passionate supporter of the diversity and inclusion agenda. She is the Executive Sponsor of the Johnson & Johnson Family of Companies Global Community Impact Program as well as the Reconciliation Action Plan (RAP)
Susan joined the board in November 2018.
Mr Serge Bernasconi
Chief Executive Officer, MedTech Europe
Mr Maurice Ben-Mayor
President Stryker South Pacific & Chairman, MTAA
Mr Andrew Frye
Senior Vice President & President, APAC, Baxter Healthcare, Chairman of APACMed
Ms Carmen Rechbauer
Chief Executive Officer, Healthshare NSW
Mr Dan Kildea
Senior Government Affairs and Policy Manager, Johnson & Johnson
Ms Natascha Millard
Senior Clinical Research Manager, Stryker
Dr. Bernadette Aliprandi-Costa
Safety & Quality Improvement Systems and Intergovernmental Relations, Australian Commission on Safety and Quality in Health Care
Bernadette holds a PhD in health outcomes research from the University of Sydney and has lead programs of work in the health care sector including managing clinical trial services; developing quality reporting frameworks; designing and implementing clinical quality registries and mechanisms for reporting health system performance.
Currently, Bernadette is leading the development and implementation of the National Clinical Trials Governance Framework and the review of the Australian Framework for Clinical Quality Registries.
Ms Annie Arnett
Vice President & General Manager, Hologic Inc.
Dr Terry Sweeney
Founder & Principal, Auxilia – Digital Health
Prof. Wendy Rogers
Professor of Clinical Ethics, Macquarie University
Mr George Faithfull
Vice President Government & Regulatory Affairs, Skryer
George is a member of the MTAA Public Affairs Committee, Chair of the MTAA Regulatory Affairs Committee, member of the APACMed Regulatory Affairs Committee, serves on the Steering Committee of the Association of Regulatory and Clinical Scientists, and was Chair of the Advamed China Regulatory Committee for several years, and member of the International Society of Arthroplasty Registries’ Global Benchmarking Working Group.
He has published work on biomaterials and joint implants, lectured in Biomedical Engineering, and has recently completed a Master of Clinical Research from Liverpool University in the UK. In 2019 George received the MTAA’s Outstanding Achievement Award for exceptional contribution to the Medical Technology Industry.
George is currently Vice President of Government and Regulatory Affairs for Stryker South Pacific.
Ms Tracey Duffy
First Assistant Secretary, Health Product Quality Division, Department of Health
Mr Jesús Rueda Rodríguez
Director International Affairs, MedTech Europe
Mr Oliver Bisazzo
Director Regulations & Industrial Policy, MedTech Europe
The regulatory team strives to facilitate ‘technical implementation’ of new and changing rules across Europe, and to communicate the positions of the MedTech Europe membership to the European Commission, the Member States, and other relevant authorities. In this, Oliver’s personal role is to represent MedTech Europe and communicate its positions towards the Medical Devices Coordination Group (MDCG), the Competent Authorities for Medical Devices (CAMD), and other stakeholders. When not working on EU regulations, Oliver also coordinates the activities of MedTech Europe’s Cardiovascular Sector Group
Prior to joining MedTech Europe, he worked at Medtronic as Director of Regulatory Policy for EMEA. In addition to this company experience, Oliver has had trade association roles in Brussels, at COCIR (the European association for the radiological, electromedical and healthcare IT industries) and at EDANA (the industry association for the nonwovens and related industries).
Mr Erik Hansson
Deputy Head of Unit, Directorate General for SANTE, Medical Devices and Health Technology Assessment, EU Commission
Erik holds a Master degree in law from the University of Uppsala, Sweden, followed by positions in law courts and co-ordination of preparations for the EU-membership in Swedish ministries and agencies. Since joining the European Commission in 1997 Erik has mainly dealt with policies relating to the single market for goods as well as finance and strategic policy planning.